Literature DB >> 8263127

The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes.

M Christ1, C Eisen, J Aktas, K Theisen, M Wehling.   

Abstract

There is increasing evidence for rapid steroid action on electrolyte transport in human mononuclear leukocytes (HML). In HML, aldosterone stimulates the Na+/H+ antiporter within a few minutes. Because a variety of hormones and growth factors activate the Na+/H+ antiporter via protein kinase C and inositol phospholipids, a possible involvement of inositol-1,4,5-trisphosphate (IP3) in the rapid effects of aldosterone in HML was investigated. The stimulation of IP3 generation was started by the addition of aldosterone, concanavalin A, or other steroids. A significant increase in IP3 levels by aldosterone (1 nmol/L, P < 0.05) was found after 1 min, similar to that found after concanavalin A (25 micrograms/mL). Aldosterone caused a concentration-dependent elevation of IP3 levels, with an apparent EC50 of approximately 0.1 nmol/L. Fludrocortisone stimulated IP3 generation at similar concentrations, whereas a weaker IP3 stimulation by glucocorticoids (hydrocortisone, dexamethasone) occurred at micromolar concentrations only. Canrenone, a potent inhibitor of classical aldosterone action, was not effective up to a concentration of 100 nmol/L. These findings show kinetic and pharmacological similarities with both the functional data on Na+/H+ antiport stimulation by aldosterone and the studies of 125I-aldosterone binding to plasma membranes of HML. Thus, these data are the first to indicate an involvement of the phosphoinositide pathway in the rapid membrane effects of aldosterone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263127     DOI: 10.1210/jcem.77.6.8263127

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts.

Authors:  K Rombouts; A Wielant; K Hellemans; D Schuppan; A Geerts
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Nuclear vs translocating steroid receptor models and the excluded middle.

Authors:  W V Welshons; B M Judy
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

Review 3.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

Review 4.  Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

Authors:  Martin Wehling
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 5.  Glucocorticoid and mineralocorticoid resistance.

Authors:  P A Komesaroff; M C Zennaro
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 6.  Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones.

Authors:  P J Davis; H C Tillmann; F B Davis; M Wehling
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

7.  Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Authors:  Wenxia Chai; Ingrid M Garrelds; Udayasankar Arulmani; Regien G Schoemaker; Jos M J Lamers; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

8.  Rapid activation of Na+/H+ exchange by aldosterone in renal epithelial cells requires Ca2+ and stimulation of a plasma membrane proton conductance.

Authors:  M Gekle; N Golenhofen; H Oberleithner; S Silbernagl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 9.  Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s.

Authors:  M Wehling
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

10.  Non-genomic regulation of intermediate conductance potassium channels by aldosterone in human colonic crypt cells.

Authors:  K A Bowley; M J Morton; M Hunter; G I Sandle
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.